Gene: ZCCHC14
Official Full Name: zinc finger CCHC-type containing 14provided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity; phosphatidylinositol binding activity; and zinc ion binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29765 | ZCCHC14 Knockout cell line (HeLa) | Human | ZCCHC14 | 1:3~1:6 | Negative | Online Inquiry |
KO29766 | ZCCHC14 Knockout cell line (HCT 116) | Human | ZCCHC14 | 1:2~1:4 | Negative | Online Inquiry |
KO29767 | ZCCHC14 Knockout cell line (HEK293) | Human | ZCCHC14 | 1:3~1:6 | Negative | Online Inquiry |
KO29768 | ZCCHC14 Knockout cell line (A549) | Human | ZCCHC14 | 1:3~1:4 | Negative | Online Inquiry |
ZCCHC14 Gene Knockout Cell Lines are specialized laboratory tools representing a significant advancement in genetic research and cellular biology. These engineered cell lines have had the ZCCHC14 gene selectively inactivated, allowing researchers to systematically investigate the gene's role in various biological processes, including RNA metabolism, cellular stress responses, and potential contributions to disease states. The knockout mechanism utilized typically involves CRISPR-Cas9 technology, which ensures precise targeting and disruption of the gene, thereby enabling a reliable model for studying gene function and associated pathways.
The primary function of the ZCCHC14 knockout cell lines lies in their capacity to dissect the biological implications of ZCCHC14 depletion. Researchers can observe phenotypic changes, alterations in gene expression profiles, and shifts in metabolic pathways, thereby elucidating the gene's involvement in critical cellular functions. These cell lines are invaluable in laboratory settings, particularly for studies examining cellular proliferation, differentiation, and apoptosis, as well as in the evaluation of drug responses and the development of potential therapeutic interventions.
The significance of ZCCHC14 knockout cell lines extends to translational research, where they may provide insights into the pathophysiology of diseases such as cancer and neurodegenerative disorders. Utilizing these cell models could enhance the design of targeted therapies and inform biopharmaceutical development focused on modulating ZCCHC14-related pathways.
What sets our ZCCHC14 Gene Knockout Cell Lines apart from alternatives is their robust validation and consistency, ensuring reproducibility in experimental setups. Our cell lines are provided with thorough documentation demonstrating genotype confirmation, making them a reliable choice for researchers looking to derive actionable insights into gene function and its implications in disease.
Investing in ZCCHC14 Gene Knockout Cell Lines is an investment in high-quality, reliable tools that empower researchers and clinicians to push the boundaries of genetic research and therapeutic discovery. Our company prides itself on extensive expertise in developing cutting-edge biological products that facilitate groundbreaking scientific exploration and progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.